An illustrated global history
How a sacred Andean crop became a European medicine, a soft-drink ingredient, a prohibited substance, and the engine of a violent global economy — told chronologically, with the arguments and the costs kept in view.
Erythroxylum coca is a domesticated shrub with a documented place in Andean society for millennia. Cocaine is an alkaloid isolated from its leaves in a German laboratory in 1859. Nearly every dispute in this history — colonial taxation, medical enthusiasm, treaty law, eradication policy — turns on whether those two things are treated as the same substance.
Long before cocaine existed as a chemical, the coca plant was a staple of Andean life — food, medicine, currency, and sacrament.
Chewed coca leaves and lime residues appear at sites in coastal Peru and the Andean highlands, among the earliest evidence of sustained plant use in the Americas.
Moche and Tiwanaku iconography depicts coca chewers and lime gourds. Leaf bundles accompany elite burials, marking coca as an offering to mountains and the dead.
The Inca administered coca plantations on the eastern slopes, distributing leaf through state channels for labour, ritual, and long-distance runners.
After early attempts to suppress coca as idolatry, colonial authorities discovered its usefulness in the silver mines of Potosí. Coca was legalised, taxed, and rationed to conscripted workers.
European chemistry pulled a single alkaloid out of the leaf, and nineteenth-century medicine and marketing did the rest.
Friedrich Gaedcke produced a crude extract; in 1859 Albert Niemann, working in Göttingen, purified and named cocaine, describing its numbing effect on the tongue.
The Corsican chemist Angelo Mariani blended coca extract with Bordeaux wine. Endorsed by popes, monarchs, and Thomas Edison, it made coca a fashionable European tonic.
Karl Koller demonstrated cocaine anaesthesia in eye surgery in Vienna — a genuine medical breakthrough that made painless ophthalmic and dental operations possible. Sigmund Freud's essay Über Coca appeared the same year, championing the drug before its dependence risks were understood.
Coca appeared in wines, lozenges, hay-fever powders, and John Pemberton's new Atlanta beverage. Cocaine was removed from Coca-Cola's formula around 1903; a de-cocainised leaf extract remains part of the flavouring.
Physicians documented addiction, psychosis, and deaths among patients and colleagues. Medical journals that had promoted cocaine as a cure for morphine dependence began publishing warnings.
Within a generation cocaine moved from pharmacy shelf to controlled substance, in a wave of national laws and international treaties.
US labelling requirements forced patent-medicine makers to disclose cocaine content, collapsing much of the market.
The first international drug treaty extended controls beyond opium to cocaine, committing signatories to restrict manufacture and trade.
The United States restricted cocaine to medical use. Enforcement was entangled from the start with racialised press campaigns that used the drug as a pretext for policing Black communities in the South.
Legal manufacture concentrated in a few licensed firms; illicit use receded in much of the West as amphetamines took its place. Andean leaf chewing continued, increasingly framed by outsiders as a problem to be eradicated.
A global prohibition regime met surging demand, and the result was one of the most profitable and violent illicit industries of the century.
Coca leaf itself was listed alongside cocaine, obliging producer states to uproot cultivation — a clause Bolivia and Peru have contested ever since on cultural grounds.
Cultivation expanded in Peru's Upper Huallaga and Bolivia's Chapare, with processing and export organised through Colombia. Cocaine re-entered North American nightlife as a luxury good.
The Medellín and Cali organisations industrialised smuggling and waged war on the Colombian state — assassinations of judges, journalists, and a presidential candidate. Pablo Escobar was killed in 1993; the Cali leadership fell soon after.
Smokable cocaine spread through under-invested US cities amid a price collapse. The 1986 Anti-Drug Abuse Act imposed penalties for crack 100 times harsher than for powder, a disparity narrowed only in 2010.
Congressional investigations, including the 1989 Kerry Committee report, documented how counter-insurgency alliances in Central America repeatedly overlapped with trafficking networks.
Eradication campaigns reshaped routes and actors more than volumes. Production is now at record highs and markets have gone global.
A multi-billion-dollar US aid programme funded aerial fumigation and military support. Cultivation shifted between regions and countries — the 'balloon effect' — rather than disappearing.
As Caribbean routes closed, Mexican organisations took control of wholesale distribution into the US, and a militarised crackdown drove more than a decade of extreme violence.
Bolivia expelled the DEA and later re-acceded to the UN convention with a reservation permitting traditional coca chewing, formalising a distinction between leaf and alkaloid.
Colombia's agreement with the FARC included voluntary crop substitution, but cultivation reached new peaks as armed successor groups and dissidents filled the vacuum.
UNODC reporting describes successive all-time highs in coca cultivation and cocaine manufacture, with rapid market growth in Western Europe, Brazil, West Africa, and Asia, and Antwerp and Rotterdam emerging as principal entry ports.
Printed edition
Every copy is printed to order after you buy it, then shipped to you — no warehouse, no remainders.
Throughlines
A traditional coca quid delivers a mild, slow dose comparable to strong coffee. Cocaine hydrochloride concentrates the alkaloid hundreds of times over. Conflating the two is the oldest confusion in this history — and the one that made a 4,000-year-old crop illegal under international law.
Cocaine was not smuggled into the world; it was launched by chemists, physicians, and advertisers. Its descendants — lidocaine, procaine, and the wider '-caine' family — remain in daily clinical use, which is why the drug still holds a legal medical schedule.
Every major enforcement success has relocated the industry rather than ended it: from Peru to Colombia, from the Caribbean to Mexico, from Miami to Antwerp. Supply has proven far more elastic than demand.
Consumption is concentrated in wealthy countries; homicide, displacement, deforestation, and incarceration fall overwhelmingly on Andean growers, transit communities, and over-policed neighbourhoods far from the point of sale.
Further reading